Followers | 16 |
Posts | 4461 |
Boards Moderated | 0 |
Alias Born | 04/13/2016 |
![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Saturday, March 11, 2023 1:55:28 PM
Different kinds of testing or procedures might be needed for these different applications. I don’t know.
The easiest applications for DS or MS are external. I knew a child born with Epidermolysis bullosa. He had to have bandages on his skin and it hurt terribly to have to peel them off every day and replace them. A spider silk bandage could have reduced the frequency of changes to perhaps every 4 or 5 days. That would have been a blessing for this poor kid. I’m guessing that bandage makers are the first to ask for DS or MS.
Only about a year ago was KBLB able to ship fibers to a few more medical companies. I’m guessing this might have included a few who specialize in internal applications. Each company will do their own testing on the fibers. The test for calcification is important in some applications, but not others, for example.
When research papers appear, they will include methods of clearing sericin and testing for clearance. How many research articles have mentioned KBLB? Pretty sure none of them. That means research is just getting started. But if a company is going to spend five million bucks to develop a new heart valve, they probably want to lock KBLB in as a sole supplier. That will be done thru a joint venture. No medical company wants to be in a situation where KBLB is shipping material to seven or eight of their competitors, all of whom are working to develop heart valves. That is the reason for a joint venture.
Recent KBLB News
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 06/10/2024 08:30:30 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 06/04/2024 04:15:03 AM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/22/2023 09:31:54 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/16/2023 09:30:34 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:43:51 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 09/11/2023 08:30:50 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 09/01/2023 08:30:52 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:35:05 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM